Docstoc

Aarkstore Enterprise || Medulloblastoma – Pipeline Review, H2 2012

Document Sample
Aarkstore Enterprise || Medulloblastoma – Pipeline Review, H2 2012 Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Medulloblastoma – Pipeline Review, H2 2012




RSS link of Global Markets Direct


Summary

Global Markets Direct’s, Medulloblastoma - Pipeline Review, H2 2012, provides an
overview of the Medulloblastoma therapeutic pipeline. This report provides
information on the therapeutic development for Medulloblastoma, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Medulloblastoma.
Medulloblastoma - Pipeline Review, H2 2012 is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Medulloblastoma.
- A review of the Medulloblastoma products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.

Table of contents:

List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Medulloblastoma Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Medulloblastoma 7
Medulloblastoma Therapeutics under Development by Companies 9
Medulloblastoma Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 12
Comparative Analysis 12
Mid Clinical Stage Products 13
Comparative Analysis 13
Early Clinical Stage Products 14
Comparative Analysis 14
Discovery and Pre-Clinical Stage Products 15
Comparative Analysis 15
Medulloblastoma Therapeutics – Products under Development by Companies 16
Medulloblastoma Therapeutics – Products under Investigation by
Universities/Institutes 17
Companies Involved in Medulloblastoma Therapeutics Development 18
Novartis AG 18
Pfizer Inc. 19
Lixte Biotechnology Holdings, Inc. 20
Archer Biosciences, Inc 21
Medulloblastoma – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Combination Products 23
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
CST-102 - Drug Profile 28
Sodium Thiosulfate - Drug Profile 29
ARC-100 - Drug Profile 30
GW572016 - Drug Profile 32




List of Figures

List of Tables are also include.




For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1




Nasopharyngeal Cancer – Pipeline Review, H2 2012

Medulloblastoma – Pipeline Review, H2 2012

Ewing Sarcoma – Pipeline Review, H2 2012

Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H2 2012

Equine Encephalitis – Pipeline Review, H2 2012

Anaplastic Astrocytoma – Pipeline Review, H2 2012

Penile Cancer – Pipeline Review, H2 2012

Natural Killer Cell Lymphomas – Pipeline Review, H2 2012
Medullary Thyroid Cancer – Pipeline Review, H2 2012

Fever – Pipeline Review, H2 2012




Search More Reports Related to This Category :


Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:10
posted:8/13/2012
language:English
pages:4